Brimonidine Tartrate 61314-0143-05
- Manufacturer
- Sandoz Inc
- Dosage Form
- Solution
- Route
- Ophthalmic
- Product Type
- Human Prescription Drug
- Marketing Start
- September 17, 2003
- Listing Expires
- December 31, 2026
- Application
- ANDA076254
Need to source Brimonidine Tartrate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Brimonidine Tartrate | 2 mg/mL |
Drug Class
Adrenergic alpha-Agonists [MoA]alpha-Adrenergic Agonist [EPC]
Selected Package
61314-0143-05Selected1 BOTTLE in 1 CARTON (61314-143-05) / 5 mL in 1 BOTTLE
Other packages for this product(2)
1 BOTTLE in 1 CARTON (61314-143-10) / 10 mL in 1 BOTTLE
1 BOTTLE in 1 CARTON (61314-143-15) / 15 mL in 1 BOTTLE